Shaily Engineering shares up 3%; UBS initiates buy with 60% upside potential

UBS has initiated coverage on Shaily Engineering Plastics with a Buy rating and a target price of Rs 4,000, citing strong growth prospects driven by its patented technology, upcoming GLP-1 generic launch, and improving utilisation across consumer and industrial segments. The brokerage expects robust earnings growth and market share gains supported by high entry barriers […]

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight. These benefits depended largely on hypothalamic GLP-1R signaling and closely mirrored the anti-aging patterns produced by rapamycin.

Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s?

The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.

Better Than Ozempic? New Oxytocin Combination Could Eliminate Side Effects

In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors. New research is offering a clearer picture of how medications that target the glucagon-like peptide-1 (GLP-1) system influence brain networks involved in nausea, thirst, and reward-driven behaviors. These new results were recently shared at Neuroscience 2025, the annual meeting of […]

JCM, Vol. 14, Pages 8326: Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed

JCM, Vol. 14, Pages 8326: Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed Journal of Clinical Medicine doi: 10.3390/jcm14238326 Authors: Alberto Martínez-Castelao José Luis Górriz Beatriz Fernández-Fernández María José Soler Juan F. Navarro-González Diabetes mellitus (DM) continues to be a global world health problem. Despite medical advances, both DM and chronic kidney […]

Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 – Seeking Alpha

Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1  Seeking Alpha High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit  Reuters Can GLP-1 drugs treat Alzheimer’s? Novo Nordisk will soon announce key results  statnews.com Key facts: Novo Nordisk trials Rybelsus for cognitive decline; analysts see stable growth  TradingView Novo Nordisk Will Soon Reveal Whether Its GLP-1 […]